{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:28:17Z","timestamp":1787041697240,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003803","name":"University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008865","name":"Xiamen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119134","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:29:10Z","timestamp":1783924150000},"page":"119134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["DDI-MMAF: Multi-modal affine fusion of visual and semantic representations for anticancer drug synergy prediction"],"prefix":"10.1016","volume":"317","author":[{"given":"Hao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuxin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peilin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzong-Yi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4554-6827","authenticated-orcid":false,"given":"Lantian","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejmech.2026.119134_b1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2026.119134_b2","series-title":"Cancer","author":"World Health Organization","year":"2025"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119134_b3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119134_b4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: Tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejmech.2026.119134_b5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/157340908784533229","article-title":"On the paradigm shift towards multitarget selective drug design","volume":"4","author":"Dessalew","year":"2008","journal-title":"Curr. Comput. - Aided Drug Des."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119134_b6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd2683","article-title":"Mechanisms of drug combinations: Interaction and network perspectives","volume":"8","author":"Jia","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119134_b7","doi-asserted-by":"crossref","first-page":"bbac075","DOI":"10.1093\/bib\/bbac075","article-title":"A review of machine learning approaches for drug synergy prediction in cancer","volume":"23","author":"Torkamannia","year":"2022","journal-title":"Brief. Bioinform."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119134_b8","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","article-title":"An unbiased oncology compound screen to identify novel combination strategies","volume":"15","author":"O\u2019Neil","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2026.119134_b9","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2024.102827","article-title":"New methods for drug synergy prediction: A mini-review","volume":"86","author":"Abbasi","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119134_b10","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1038\/s41467-019-09799-2","article-title":"Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen","volume":"10","author":"Menden","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119134_b11","series-title":"Ensemble Machine Learning: Methods and Applications","first-page":"307","article-title":"Random forest for bioinformatics","author":"Qi","year":"2012"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119134_b12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.cmpb.2013.04.018","article-title":"The application of support vector regression for prediction of the antiallodynic effect of drug combinations in the mouse model of streptozocin-induced diabetic neuropathy","volume":"111","author":"Sa\u0142at","year":"2013","journal-title":"Comput. Methods Programs Biomed."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119134_b13","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1021\/acs.jcim.3c00709","article-title":"AttenSyn: An attention-based deep graph neural network for anticancer synergistic drug combination prediction","volume":"64","author":"Wang","year":"2024","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119134_b14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s44386-025-00034-1","article-title":"A review of deep learning approaches for drug synergy prediction in cancer","volume":"2","author":"Li","year":"2025","journal-title":"Npj Drug Discov."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119134_b15","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","article-title":"DeepSynergy: predicting anti-cancer drug synergy with deep learning","volume":"34","author":"Preuer","year":"2017","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119134_b16","doi-asserted-by":"crossref","first-page":"bbab390","DOI":"10.1093\/bib\/bbab390","article-title":"DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations","volume":"23","author":"Wang","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119134_b17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1010951","article-title":"MGAE-DC: Predicting the synergistic effects of drug combinations through multi-channel graph autoencoders","volume":"19","author":"Zhang","year":"2023","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119134_b18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12859-024-05765-y","article-title":"MFSynDCP: Multi-source feature collaborative interactive learning for drug combination synergy prediction","volume":"25","author":"Dong","year":"2024","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119134_b19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13321-023-00690-3","article-title":"DFFNDDS: Prediction of synergistic drug combinations with dual feature fusion networks","volume":"15","author":"Xu","year":"2023","journal-title":"J. Cheminformatics"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119134_b20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13321-024-00859-4","article-title":"piscesCSM: Prediction of anticancer synergistic drug combinations","volume":"16","author":"AlJarf","year":"2024","journal-title":"J. Cheminformatics"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119134_b21","doi-asserted-by":"crossref","first-page":"bbae699","DOI":"10.1093\/bib\/bbae699","article-title":"Multimodal deep learning approaches for precision oncology: A comprehensive review","volume":"26","author":"Yang","year":"2024","journal-title":"Brief. Bioinform."},{"issue":"14","key":"10.1016\/j.ejmech.2026.119134_b22","doi-asserted-by":"crossref","first-page":"i501","DOI":"10.1093\/bioinformatics\/btz318","article-title":"MOLI: Multi-omics late integration with deep neural networks for drug response prediction","volume":"35","author":"Sharifi-Noghabi","year":"2019","journal-title":"Bioinformatics"},{"issue":"7480","key":"10.1016\/j.ejmech.2026.119134_b23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature12831","article-title":"Inconsistency in large pharmacogenomic studies","volume":"504","author":"Haibe-Kains","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119134_b24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s12539-023-00558-y","article-title":"Predicting drug synergy and discovering new drug combinations based on a graph autoencoder and convolutional neural network","volume":"15","author":"Li","year":"2023","journal-title":"Interdiscip. Sci.: Comput. Life Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119134_b25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/ci00057a005","article-title":"SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules","volume":"28","author":"Weininger","year":"1988","journal-title":"J. Chem. Inf. Comput. Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119134_b26","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/bioinformatics\/btz682","article-title":"BioBERT: A pre-trained biomedical language representation model for biomedical text mining","volume":"36","author":"Lee","year":"2020","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119134_b27","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s42256-022-00557-6","article-title":"Accurate prediction of molecular properties and drug targets using a self-supervised image representation learning framework","volume":"4","author":"Zeng","year":"2022","journal-title":"Nat. Mach. Intell."},{"issue":"19","key":"10.1016\/j.ejmech.2026.119134_b28","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1021\/acs.jcim.5c01467","article-title":"Predicting drug\u2013drug interaction via dual-drug visual representation","volume":"65","author":"Xie","year":"2025","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119134_b29","doi-asserted-by":"crossref","DOI":"10.1609\/aaai.v32i1.11671","article-title":"FiLM: Visual reasoning with a general conditioning layer","volume":"32","author":"Perez","year":"2018","journal-title":"Proceedings of the AAAI Conference on Artificial Intelligence"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119134_b30","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe","year":"1953","journal-title":"Arzneimittel-Forschung"},{"issue":"15","key":"10.1016\/j.ejmech.2026.119134_b31","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1021\/jm9602928","article-title":"The properties of known drugs. 1. Molecular frameworks","volume":"39","author":"Bemis","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119134_b32","doi-asserted-by":"crossref","unstructured":"Kaiming He, Xiangyu Zhang, Shaoqing Ren, Jian Sun, Deep Residual Learning for Image Recognition, in: Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition, CVPR, 2016, pp. 770\u2013778.","DOI":"10.1109\/CVPR.2016.90"},{"key":"10.1016\/j.ejmech.2026.119134_b33","series-title":"9th International Conference on Learning Representations","article-title":"An image is worth 16x16 words: Transformers for image recognition at scale","author":"Dosovitskiy","year":"2021"},{"key":"10.1016\/j.ejmech.2026.119134_b34","series-title":"Proceedings of the 2019 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies, Volume 1 (Long and Short Papers)","first-page":"4171","article-title":"BERT: Pre-training of deep bidirectional transformers for language understanding","author":"Devlin","year":"2019"},{"key":"10.1016\/j.ejmech.2026.119134_b35","series-title":"Proceedings of the IEEE International Conference on Computer Vision","first-page":"618","article-title":"Grad-CAM: Visual explanations from deep networks via gradient-based localization","author":"Selvaraju","year":"2017"},{"issue":"41","key":"10.1016\/j.ejmech.2026.119134_b36","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1038\/onc.2008.245","article-title":"PI3K pathway alterations in cancer: variations on a theme","volume":"27","author":"Yuan","year":"2008","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119134_b37","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119134_b38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1593\/tlo.09277","article-title":"Biomarker development for the clinical activity of the mTOR inhibitor everolimus (RAD001): Processes, limitations, and further proposals","volume":"3","author":"O\u2019Reilly","year":"2010","journal-title":"Transl. Oncol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119134_b39","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","article-title":"Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity","volume":"7","author":"Maira","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"7404","key":"10.1016\/j.ejmech.2026.119134_b40","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11156","article-title":"Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer","volume":"486","author":"Misale","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119134_b41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1947601911408079","article-title":"RAS interaction with PI3K: More than just another effector pathway","volume":"2","author":"Castellano","year":"2011","journal-title":"Genes Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119134_b42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2010.10.031","article-title":"AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity","volume":"19","author":"Chandarlapaty","year":"2011","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119134_b43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/ijms22010173","article-title":"PI3K\/AKT\/mTOR signaling pathway in breast cancer: From molecular landscape to clinical aspects","volume":"22","author":"Miricescu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119134_b44","series-title":"Proceedings of the 32nd International Conference on Neural Information Processing Systems","first-page":"9525","article-title":"Sanity checks for saliency maps","author":"Adebayo","year":"2018"},{"issue":"12","key":"10.1016\/j.ejmech.2026.119134_b45","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s42256-021-00418-8","article-title":"Geometric deep learning on molecular representations","volume":"3","author":"Atz","year":"2021","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.ejmech.2026.119134_b46","series-title":"International Conference on Machine Learning","first-page":"20503","article-title":"Equibind: Geometric deep learning for drug binding structure prediction","author":"St\u00e4rk","year":"2022"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119134_b47","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41598-021-81007-y","article-title":"A high-throughput cell-based assay pipeline for the preclinical development of bacterial DsbA inhibitors as antivirulence therapeutics","volume":"11","author":"Verderosa","year":"2021","journal-title":"Sci. Rep."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:07:45Z","timestamp":1787040465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":47,"alternative-id":["S0223523426005799"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119134","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DDI-MMAF: Multi-modal affine fusion of visual and semantic representations for anticancer drug synergy prediction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119134"}}